# First-in-human Study of S-588210 (S-488210+S-488211)

> **NCT04316689** · PHASE1 · COMPLETED · sponsor: **Shionogi** · enrollment: 10 (actual)

## Conditions studied

- Lung Cancer
- Head and Neck Cancer
- Bladder Cancer
- Esophageal Cancer
- Mesothelioma

## Interventions

- **BIOLOGICAL:** S-488210
- **BIOLOGICAL:** S-488211

## Key facts

- **NCT ID:** NCT04316689
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-30
- **Primary completion:** 2021-09-22
- **Final completion:** 2021-09-22
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04316689

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04316689, "First-in-human Study of S-588210 (S-488210+S-488211)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04316689. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*